Concepedia

Stephen V. Frye

SV

Statistics

Publications

117

Citations

14.3K

H-Index

55

Active since

1985

Affiliations

University of North Carolina at Chapel Hill(Current)

University of Toronto

Structural Genomics Consortium

Children's Healthcare of Atlanta

Emory University

Stephen V. Frye is an author at University of North Carolina at Chapel Hill specializing in pharmacology, medicine, and drug discovery.

Publications per year

1985–2024

117

Publications

117

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Wei Xu, Hui Yang, Ying Liu et al. · Cancer Cell · 2011 · 2.8K citations · Full text

Life Sciences, Biochemistry, Pharmacology +8

The promise and peril of chemical probes

C.H. Arrowsmith, James E. Audia, Christopher P. Austin et al. · Nature Chemical Biology · 2015 · 850 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +12

Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer

Martin C. Whittle, Kazuhiro Nakamura, Amy N. Abell et al. · Cell · 2012 · 744 citations · Full text

Medicine, Molecular Biology, Oncology +12

A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells

Masoud Vedadi, Dalia Baršytė-Lovejoy, Feng Liu et al. · Nature Chemical Biology · 2011 · 531 citations

Life Sciences, Biochemistry, Pharmacology +9

An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1

Kyle D. Konze, Anqi Ma, Fengling Li et al. · ACS Chemical Biology · 2013 · 466 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 117